JBIR-120: a new growth inhibitor of hormone-refractory prostate cancer cells

J Antibiot (Tokyo). 2012 Jul;65(7):373-5. doi: 10.1038/ja.2012.32. Epub 2012 Apr 25.

Authors

Teppei Kawahara¹, Takahiro Hosoya, Masao Tsukamoto, Sachiko Okabe, Hideki Yamamura, Masayuki Hayakawa, Hiroyuki Seimiya, Motoki Takagi, Kazuo Shin-Ya

Affiliation

¹ Biomedicinal Information Research Center, Japan Biological Informatics Consortium, Koto-ku, Tokyo, Japan.

PMID: 22534652
DOI: 10.1038/ja.2012.32

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Antineoplastic Agents / chemistry
Antineoplastic Agents / isolation & purification
Antineoplastic Agents / pharmacology*
Cell Line, Tumor
Humans
Male
Prostatic Neoplasms / drug therapy*
Prostatic Neoplasms / pathology
Pyridines / chemistry
Pyridines / isolation & purification
Pyridines / pharmacology*
Receptors, Androgen / metabolism*
Streptomyces / metabolism*
ortho-Aminobenzoates / chemistry
ortho-Aminobenzoates / isolation & purification
ortho-Aminobenzoates / pharmacology*

Substances

Antineoplastic Agents
JBIR-120
Pyridines
Receptors, Androgen
ortho-Aminobenzoates